Literature DB >> 32108989

Consensus on the diagnosis and treatment of hepatic fibrosis (2019).

Lun Gen Lu1, Hong You2, Wei Fen Xie3, Ji Dong Jia2.   

Abstract

Hepatic fibrosis is a reparative response of diffuse over deposition and abnormal distribution of extracellular matrix (collagen, glycoprotein and proteoglycans) after exposure to various kinds of liver injuries, and is a key step in the developmental process of various chronic liver diseases to cirrhosis. Recently, many advances in our understanding of hepatic fibrosis have been recognized through the basic and clinical research. Therefore, this consensus summarized and gave 15 evidence-based recommendations on the diagnosis and evaluation, treatment, drug development and application of hepatic fibrosis. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  consensus; diagnosis; hepatic fibrosis; liver biopsy; therapeutics

Year:  2020        PMID: 32108989     DOI: 10.1111/1751-2980.12854

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  2 in total

1.  Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index for Detecting Liver Fibrosis in Patients With Autoimmune Hepatitis: A Meta-Analysis.

Authors:  Bingtian Dong; Yuping Chen; Guorong Lyu; Xiaocen Yang
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

2.  Uncovering the Pharmacological Mechanisms of Gexia-Zhuyu Formula (GXZY) in Treating Liver Cirrhosis by an Integrative Pharmacology Strategy.

Authors:  Xu Cao; Yijun Liang; Ruijia Liu; Xiaobin Zao; Jiaying Zhang; Guang Chen; Ruijie Liu; Hening Chen; Yannan He; Jiaxin Zhang; Yong'an Ye
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.